Subsequent experimental validation confirmed the HIF-1α-induced down-regulation of NAT2 in myopic sclera and demonstrated that genetic modulation of NAT2 expression in murine sclera directly influenced myopia progression. The gene discussed is NAT2; the disease is myopia.